Overview of the LUX-Lung clinical trial program of afatinib for non-small cell lung cancer
Author:
Funder
Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI)
Publisher
Elsevier BV
Subject
Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Reference45 articles.
1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017
2. American Cancer Society. What is non-small cell lung cancer?, ; 2016 [accessed 05 May 2017].
3. Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
4. Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis;Lee;J Natl Cancer Inst,2013
5. Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data;Jorge;Braz J Med Biol Res,2014
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New-onset keratitis associated with epidermal growth factor receptor-based targeted therapies in Han Chinese patients with lung cancer: A multi-center cohort study;The Ocular Surface;2024-07
2. Silencing of lncRNA LOC105376794 promotes migration, invasion, and gefitinib resistance of lung adenocarcinoma cells with EGFR 19del mutation by ATF4/CHOP axis and ERK phosphorylation;Neoplasma;2024
3. Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes;Cancers;2023-10-31
4. Afatinib in paediatric patients with recurrent/refractory ErbB-dysregulated tumours: Results of a phase I/expansion trial;European Journal of Cancer;2023-07
5. Advances in the Treatment of Rare Epidermal Growth Factor Receptor Mutations in Advanced Nonsmall-Cell Lung Cancer;Technology in Cancer Research & Treatment;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3